Presence of cholesterol 7 alpha-hydroxylase enzyme protein in COS-cells leads to increased HMG CoA reductase activity. 1994

E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
Department of Clinical Chemistry, Huddinge Hospital, Sweden.

Transfection of COS-cells with a cDNA coding for human cholesterol 7 alpha-hydroxylase resulted in significant production of cholesterol 7 alpha-hydroxylase enzyme and intracellular accumulation of the product, 7 alpha-hydroxycholesterol. Presence of this enzyme activity was always associated with increased HMG CoA reductase activity. In five different independent transfection experiments resulting in a cholesterol 7 alpha-hydroxylase activity of 0.26 +/- 0.05 pmol/min/mg in the transfected cells, the HMG CoA reductase activity increased to 158 +/- 14% of that of the control cells (p < 0.01). This change was not associated with significant changes in the cholesterol content or LDL-receptor expression of the COS-cells. It is evident that the two key enzymes in cholesterol synthesis and degradation interact with each other also in extra-hepatic cells that are unable to degrade cholesterol into bile acids. Possible mechanisms for the finding is discussed.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002790 Cholesterol 7-alpha-Hydroxylase A membrane-bound cytochrome P450 enzyme that catalyzes the 7-alpha-hydroxylation of CHOLESTEROL in the presence of molecular oxygen and NADPH-FERRIHEMOPROTEIN REDUCTASE. This enzyme, encoded by CYP7, converts cholesterol to 7-alpha-hydroxycholesterol which is the first and rate-limiting step in the synthesis of BILE ACIDS. CYP7,CYP7A,Cytochrome P-450 CYP7,CYP 7,CYP 7A,Cholesterol 7-alpha-Monooxygenase,Cholesterol 7alpha-Hydroxylase,Cholesterol-7-Hydroxylase,Cytochrome P450 7,Cholesterol 7 Hydroxylase,Cholesterol 7 alpha Hydroxylase,Cholesterol 7 alpha Monooxygenase,Cholesterol 7alpha Hydroxylase,Cytochrome P 450 CYP7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006888 Hydroxycholesterols Cholesterol which is substituted by a hydroxy group in any position.
D006903 Hydroxymethylglutaryl CoA Reductases Enzymes that catalyze the reversible reduction of alpha-carboxyl group of 3-hydroxy-3-methylglutaryl-coenzyme A to yield MEVALONIC ACID. HMG CoA Reductases,3-Hydroxy-3-methylglutaryl CoA Reductase,HMG CoA Reductase,Hydroxymethylglutaryl CoA Reductase,3 Hydroxy 3 methylglutaryl CoA Reductase,CoA Reductase, 3-Hydroxy-3-methylglutaryl,Reductase, 3-Hydroxy-3-methylglutaryl CoA
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014162 Transfection The uptake of naked or purified DNA by CELLS, usually meaning the process as it occurs in eukaryotic cells. It is analogous to bacterial transformation (TRANSFORMATION, BACTERIAL) and both are routinely employed in GENE TRANSFER TECHNIQUES. Transfections
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D018076 DNA, Complementary Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe. Complementary DNA,cDNA,cDNA Probes,Probes, cDNA

Related Publications

E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
January 1997, Sub-cellular biochemistry,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
September 1985, FEBS letters,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
February 1988, Journal of lipid research,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
July 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
June 1977, Experimental and molecular pathology,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
December 1983, Life sciences,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
January 1987, Advances in experimental medicine and biology,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
November 1990, Nihon rinsho. Japanese journal of clinical medicine,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
May 1980, Archives of biochemistry and biophysics,
E Sudjana-Sugiaman, and G Eggertsen, and P Sjöblom, and Y Maeda, and M Rudling, and K Okuda, and I Björkhem
August 1992, Journal of lipid research,
Copied contents to your clipboard!